In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Allergan pays $3.1bn for Inamed

Executive Summary

Dermatology company and Botox developer Allergan has completed its acquisition of Inamed (medical dermatology products, breast implants, and obesity devices) for $84 per share or $3.1bn, roughly 8 times Inamed's 2004 sales. It successfully outbid Medicis's earlier $2.7bn proposition for the company.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies